Key statistics dashboard for Compugen Ltd. (CGEN). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Compugen Ltd., an Israeli-based company established in 1993 and headquartered in Holon, is a clinical-stage enterprise focused on the discovery, development, and commercialization of therapeutic and product candidates. Its operations extend across Israel, the United States, and Europe.
Stock Data
| Price | $2.41 |
| Market Cap | $228M |
| Enterprise Value | $220.6M |
| Beta | 2.77 |
| Exchange | NASDAQ |
| Country | IL |
Valuation Multiples
| P/E Ratio | 6.42 |
| Price / Book | 2.57 |
| P/S | 3.08 |
| EV/EBITDA | 6.26 |
| EV/Sales | 2.98 |
| EV/FCF | 0.00 |
| P/FCF | 0.00 |
| Earnings Yield | 15.43% |
| FCF Yield | 0.00% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 86.89% |
| EBIT Margin | 47.63% |
| EBITDA Margin | 47.63% |
| Operating Margin | 40.94% |
| Net Margin | 47.55% |
| Return on Equity | 42.57% |
| Return on Assets | 25.43% |
| Return on Invested Capital | 26.00% |
| Return on Capital Employed | 26.18% |
Financial Health
| Current Ratio | 5.72 |
| Quick Ratio | 5.72 |
| Cash Ratio | 0.45 |
| Debt / Equity | 0.03 |
| Debt / Assets | 2.18% |
| Net Debt / EBITDA | -0.21 |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 6 |
| Altman Z-Score | -0.38 |
Per-Share Data
| Revenue per share | 0.78 |
| Book Value per share | 0.94 |
| Cash per share | 1.32 |
| FCF per share | 0.00 |
| Tangible Book Value per share | 0.94 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 13 |
| Hold | 0 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 14 |
| Avg rating (1-5) | 0.86 |
Related companies: CRBP · CRDF · CYBN · IPHA · MIST · MOLN · NVCT
Explore sector: Healthcare · Biotechnology
More sections of CGEN: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks